ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Ligandal Is Developing Potential Antidote And Vaccine To SARS-CoV-2 prnasia
April 14, 2020Biological engineering company Ligandal, Inc. is applying its unique peptide-based delivery technologies to develop a prospective antidote and vaccine for SARS-CoV-2 (the novel coronavirus) to be formulated and developed in response to the worldwide pande
Pharma Sources Insight January 2025
